Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Serum fructosamine and subsequent breast cancer risk: a nested case-control study in the ORDET prospective cohort study.

Platek M, Krogh V, Micheli A, Browne R, Meneghini E, Sieri S, Schünemann HJ, Pala V, Barba M, Wilding GE, Berrino F, Muti P. Serum fructosamine and subsequent breast cancer risk: a nested case-control study in the ORDET prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1):271-4.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.